Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-042044
Date:2021-06-18
Issuer: LOGICBIO THERAPEUTICS, INC. (LOGC)
Original Submission Date:

Reporting Person:

KAY MARK A
C/O LOGICBIO THERAPEUTICS, INC.
65 HAYDEN AVE, FLOOR 2 LEXINGTON, MA 02421

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 4.05 2021-06-18 deemed execution date A 5,000 (a) 2031-06-18 common stock 5,000 $4.05 5,000 direct
Footnotes
IDfootnote
f1 the options were granted by the issuer pursuant to its 2018 equity incentive plan in relation to the reporting person's service on the issuer's scientific advisory board. the options will vest over two years: 50% of the options will vest on the first anniversary of the grant date with the remaining 50% vesting on the second anniversary of the grant date, subject to the reporting person's continued service with the issuer through each vesting date.

Elevate your investments